Cost-effectiveness of sofosbuvir/ribavirin in patients with genotype 2 chronic hepatitis C: An analysis with real-world outcomes from a multicenter cohort in Japan

Norihiro Furusyo
Ataru Igarashi
Eiichi Ogawa
Hideyuki Nomura
Kazufumi Dohmen
Nobuhiko Higashi
Kazuhiro Takahashi
Akira Kawano
Koichi Azuma
Takeaki Satoh
Makoto Nakamuta
Toshimasa Koyanagi
Masaki Kato
Shinji Shimoda
Eiji Kajiwara
Jun Hayashi

HEPATOLOGY

WILEY

https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=JSTA_CEL&SrcApp=J_Gate_JST&DestLinkType=FullRecord&KeyUT=WOS:000412089801740&DestApp=WOS_CPL